[Vaccination against papillomavirus : outstanding issues].

Area of Science:

• Oncology
• Virology
• Public Health

Background:

• Human papillomavirus (HPV) is a major cause of several human cancers.
• Approximately 5% of global cancer cases are attributed to HPV infections.
• HPV-induced cancers include those of the cervix, vagina, vulva, anus, penis, and tonsils, with viral induction rates varying significantly.

Purpose of the Study:

• To review the current understanding of HPV vaccination.
• To discuss the established role of prophylactic anti-HPV vaccination in cervical cancer prevention.
• To explore the ongoing debates and outstanding issues regarding its application in preventing other HPV-related cancers.

Main Methods:

• Literature review of existing studies on HPV vaccination and HPV-induced cancers.
• Analysis of data on the efficacy of HPV vaccination in different cancer types.
• Synthesis of current scientific consensus and areas of controversy.

Main Results:

• Prophylactic anti-HPV vaccination is proven effective in preventing cervical cancers.
• The effectiveness and necessity of HPV vaccination for other HPV-associated cancers are not yet fully established.
• Detection of HPV-induced lesions can be challenging, highlighting the importance of prevention.

Conclusions:

• HPV vaccination is a critical tool for reducing the burden of cervical cancer.
• Further research and discussion are needed to define the optimal role of HPV vaccination in preventing a broader spectrum of HPV-related malignancies.
• Addressing outstanding issues in HPV vaccination strategies is essential for comprehensive cancer control.